Artal Group S.A. Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$21.87 - $28.24 $8.75 Million - $11.3 Million
400,000 Added 66.67%
1,000,000 $26 Million
Q1 2024

May 13, 2024
BUY
$27.21 - $39.48 $10.9 Million - $15.8 Million
400,000 Added 200.0%
600,000 $17.2 Million
Q4 2023

Feb 09, 2024
BUY
$21.2 - $31.03 $4.24 Million - $6.21 Million
200,000 New
200,000 $6.12 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email